Rebamipide attenuates nonsteroidal anti-inflammatory drugs (NSAID) induced lipid peroxidation by the manganese superoxide dismutase (MnSOD) overexpression in gastrointestinal epithelial cells

Journal of Physiology and Pharmacology

Volumn 63, Issue 2, 2012, Pages 137-142

  Nagano, Y ^a,c   Matsui, H ^a   Shimokawa, O ^a   Hirayama, A ^b   Tamura, M ^a   Nakamura, Y ^c   Kaneko, T ^a   Rai, K ^a   Indo, H P ^d   Majima, H J ^d   Hyodo, I ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TSUKUBA UNIVERSITY OF TECHNOLOGY   (Japan)

^c RIKEN BIORESOURCE CENTER   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Gastrointestinal epithelial cells; Lipid peroxidation; Nonsteroidal anti inflammatory drugs; Prostaglandin; Rebamipide; Superoxide dismutase

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; ENZYME ANTIBODY; INDOMETACIN; MANGANESE SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; REBAMIPIDE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG INHIBITION; DRUG MECHANISM; ELECTRON SPIN RESONANCE; INTESTINE EPITHELIUM CELL; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SMALL INTESTINE; SPIN TRAPPING; STOMACH EPITHELIUM; STOMACH PROTECTION; WESTERN BLOTTING;

ALANINE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; ANTIOXIDANTS; CELL LINE; EPITHELIAL CELLS; INTESTINE, SMALL; LIPID PEROXIDATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; QUINOLONES; RATS; STOMACH; SUPEROXIDE DISMUTASE;

EID: 84861861656     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 2008; 135: 41-60.
2. Del Valle J. Peptic ulcer disease and related disorders. In: Harrison's Principles of Internal Medicine, AS Fauci, DL Kasper, DL Longo, E Braunwald, SL Hauser (eds). New York, McGraw-Hill Professional, 2008, pp. 1855-1872.
3. Cryer B, Spechler SJ. Peptic ulcer disease. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease, M Feldman, LS Friedman, LJ Brandt (eds). Philadelphia, Saunders, 2006, pp. 1089-1110.
4. Matsui H, Shimokawa O, Kaneko T, et al. The pathophysiology of non steroidal antiinflammatory drugs (NSAID)-induced mucosal injures in stomach and small intestine. J Clin Biochem Nutr 2011; 48: 107-111.
5. Murphy M P, Smith RA. Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev 2000; 41: 235-250.
6. Nagano Y, Matsui H, Muramatsu M, et al. Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells. Dig Dis Sci 2005; 50(Suppl 1): S76-S83.
7. Nagano Y, Matsui H, Tamura M, et al. NSAIDs and acidic environment induce gastric mucosal cellular mitochondrial dysfunction. Digestion 2012; 85: 131-135.
8. Miao L, St Clair DK. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 2009; 47: 344-356.
9. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 2002; 33: 337-349.
10. Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G. The NF-kappaB-mediated control of ROS and JNK signaling. Histol Histopathol 2006; 21: 69-80.
11. Ishihara T, Tanaka K, Tashiro S, Yoshida K, Mizushima T. Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis. Biochem Pharmacol 2010; 79: 1622-1633.
12. Higuchi K, Umegaki E, Watanabe T, et al. Present status and strategy of NSAIDs-induced small bowel injury. J Gastroenterol 2009; 44: 879-888.
13. Ogura A, Oowada S, Kon Y, et al. Redox regulation in radiation-induced cytochrome c release from mitochondria of human lung carcinoma A549 cells. Cancer Lett 2009; 277: 64-71.
14. Omatsu T, Naito Y, Handa O, et al. Involvement of reactive oxygen species in indomethacin-induced apoptosis of small intestinal epithelial cells. J Gastroenterol 2009; 44(Suppl 19): 30-34.
15. th anniversary of rebamipide: looking ahead to the new mechanisms and new applications. Dig Dis Sci 2005; 50(Suppl 1): S3-S11.
16. Hiratsuka T, Futagami S, Shindo T, et al. Rebamipide reduces indomethacin-induced gastric injury in mice via down-regulation of ICAM-1 expression. Dig Dis Sci 2005; 50(Suppl 1): S84-S89.
17. Naito Y, Iinuma S, Yagi N, et al. Prevention of indomethacin-induced gastric mucosal injury in Helicobacter pylori-negative healthy volunteers: a comparison study rebamipide vs. famotidine. J Clin Biochem Nutr 2008; 43: 34-40.
18. Niwa Y, Nakamura M, Ohmiya N, et al. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gastroenterol 2008; 43: 270-276.
19. Naito Y, Mizushima K, Yoshikawa T. Global analysis of gene expression in gastric ischemia-reperfusion: a future therapeutic direction for mucosal protective drugs. Dig Dis Sci 2005; 50(Suppl 1): S45-S55.
20. Yoshikawa T, Naito Y, Tanigawa T, Kondo M. Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance. Arzneimittelforschung 1993; 43: 363-366.
21. Naito Y, Yoshikawa T, Tanigawa T, et al. Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study. Free Radic Biol Med 1995; 18: 117-123.
22. Kim H, Seo J Y, Kim KH. Inhibition of lipid peroxidation, NF-kappaB activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells. Dig Dis Sci 2000; 45: 621-628.
23. Kamibayashi M, Oowada S, Kameda H, et al. Synthesis and characterization of a practically better DEPMPO-type spin trap, 5-(2,2-dimethyl-1,3-propoxy cyclophosphoryl)-5-methyl-1-pyrroline N-oxide (CYPMPO). Free Radic Res 2006; 40: 1166-1172.
24. Matsui H, Murata Y, Hirano K, et al. Hydrogen peroxide-induced cellular injury is associated with increase in endogenous fluorescence from rat gastric mucosal epithelial cell culture: A new method for detecting oxidative cellular injury by fluorescence measurement. J Gastroenterol 1998; 33: 318-325.
25. Quaroni A, Wands J, Trelstad RL, Isselbacher KJ. Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biol 1979; 80: 248-265.
26. Kim CD, Hong KW. Preventive effect of rebamipide on gastric mucosal cell damage evoked by activation of formyl-methionyl-leucyl-phenylalanine receptors of rabbit neutrophils. J Pharmacol Exp Ther 1997; 281: 478-483.
27. Nagano C, Azuma A, Ishiyama H, Sekiguchi K, Imagawa K, Kikuchi M. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils. J Pharmacol Exp Ther 2001; 297: 388-394.
28. Davies GR, Simmonds NJ, Stevens TR, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35: 179-185.
29. Amagase K, Inaba A, Senta T, et al. Gastric ulcerogenic and healing impairment effects of risedronate, a nitrogen-containing bisphosphonate in rats. Comparison with alendronate and minodronate. J Physiol Pharmacol 2011; 62: 609-618.
30. Kim HP, Roe JH, Chock PB, Yim MB. Transcriptional activation of the human manganese superoxide dismutase gene mediated by tetradecanoylphorbol acetate. J Biol Chem 1999; 274: 37455-37460.
31. Jones MK, Padilla OR, Zhu E. Survivin is a key factor in the differential susceptibility of gastric endothelial and epithelial cells to alcohol-induced injury. J Physiol Pharmacol 2010; 61: 253-264.
32. Filaretova LP, Bagaeva TR, Morozova OY, Zelena D. The healing of NSAID-induced gastric lesion may be followed by small intestinal and cardiovascular side effects. J Physiol Pharmacol 2011; 62: 619-625.
33. Rai K, Matsui H, Kaneko T, et al. Lansoprazole inhibits mitochondrial superoxide production and cellular lipid peroxidation induced by indomethacin in RGM1 cells. J Clin Biochem Nutr 2011; 49: 25-30.